Aktie A038070 SEOULIN BIOSCIENCE CO.,LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Seoulin Bioscience Co.,Ltd.

Aktien

A038070

KR7038070009

A038070

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 03.05.2024 		% 5 Tage % 1. Jan.
8.770 KRW +0,11 % Intraday Chart für Seoulin Bioscience Co.,Ltd. +0,69 % -4,67 %
20.03. Seoulin Bioscience Co.,Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Seoulin Bioscience Co.,Ltd. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Seoulin Bioscience Co.,Ltd.(KOSDAQ:A038070) dropped from S&P Global BMI Index
Light Farm Tech Co., Ltd. announced that it has received KRW 1.999995 billion in funding from Seoulin Bioscience Co.,Ltd.
Light Farm Tech Co., Ltd. announced that it expects to receive KRW 1.999995 billion in funding from Seoulin Bioscience Co.,Ltd. and other investors
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Seoulin Bioscience Co.,Ltd. announced that it has received KRW 30 billion in funding from Shinhan Investment Corp., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, Mirae Asset Capital Co,Ltd., Investment Arm, Cornerstone Investment Partners Co., Ltd., and other investors
Seoulin Bioscience Co.,Ltd. announced that it expects to receive KRW 30 billion in funding from Shinhan Investment Corp., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, Mirae Asset Capital Co,Ltd., Investment Arm, Cornerstone Investment Partners Co., Ltd., and other investors
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Seoulin Bioscience Co.,Ltd.(KOSDAQ:A038070) added to S&P Global BMI Index
Seoulin Bioscience Co.,Ltd.'s Equity Buyback announced on June 11, 2019, has expired.
Tranche Update on Seoulin Bioscience Co.,Ltd.'s Equity Buyback Plan announced on August 8, 2019.
Seoulin Bioscience Co.,Ltd.'s Equity Buyback announced on August 8, 2019, has expired with 92,246 shares, representing 1.2% for KRW 802.37 million.
Seoulin Bioscience Co.,Ltd. announces an Equity Buyback for KRW 1,000 million worth of its shares.
Seoulin Bioscience Co.,Ltd. authorizes a Buyback Plan.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A038070 Aktie
  4. Nachrichten Seoulin Bioscience Co.,Ltd.
  5. Andere Sprachen